Detalles de la búsqueda
1.
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
N Engl J Med
; 386(19): 1793-1803, 2022 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35544387
2.
Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials.
HIV Med
; 24(3): 290-300, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36912172
3.
Virological failure of staggered and simultaneous treatment interruption in HIV patients who began Efavirenz-based regimens after allergic reactions to nevirapine.
AIDS Res Ther
; 10(1): 4, 2013 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-23347647
4.
Recommendations from Thai stakeholders about protecting HIV remission ('cure') trial participants: report from a participatory workshop.
Int Health
; 12(6): 567-574, 2020 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33165551
5.
Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs.
Int J Infect Dis
; 68: 61-68, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29410254
6.
Three suitable antigens for delayed-type hypersensitivity skin testing in a tropical country like Thailand.
Asian Pac J Allergy Immunol
; 24(2-3): 143-52, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17136880
7.
Ritonavir-boosted lopinavir as maintenance monotherapy in HIV-infected patients who achieved viral suppression during a second-line protease inhibitor-based regimen: a pilot randomized trial (BIDI-MONO).
J Int Assoc Provid AIDS Care
; 13(4): 353-60, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24378514
8.
Ritonavir-boosted lopinavir as maintenance monotherapy in HIV-infected patients who achieved viral suppression during a second-line protease inhibitor-based regimen: a pilot randomized trial (BIDI-MONO).
J Int Assoc Provid AIDS Care
; 13(4): 353-60, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25513033
9.
Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting.
AIDS Res Hum Retroviruses
; 26(2): 139-48, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20156097
10.
Three suitable antigens for delayed-type hypersensitivity skin testing in a tropical country like Thailand.
Asian Pac J Allergy Immunol
; 2006 Jun-Sep; 24(2-3): 143-52
Artículo
en Inglés
| IMSEAR | ID: sea-36737
Resultados
1 -
10
de 10
1
Próxima >
>>